| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/05/2000 | US6114559 Silicone-substituted cinnamamide/malonamide/malonate compounds and photoprotective compositions comprised thereof |
| 09/05/2000 | US6114549 Process of making 3-phenyl-1-methylenedioxyphenyl-indane-2-carboxylic acid derivatives |
| 09/05/2000 | US6114545 Inhibitors of cholesterol esterase |
| 09/05/2000 | US6114537 Process for scavenging thiols |
| 09/05/2000 | US6114536 Indolin-2-one derivatives |
| 09/05/2000 | US6114533 2,4-pentadienoic acid derivatives having retinoid-like biological activity |
| 09/05/2000 | US6114531 Reacting 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8 -naphthyridine-3-carboxylic acid with a fused aminoaromatic salt to from trovafloxacin |
| 09/05/2000 | US6114530 Isoquiolinamines and phthalazinamines useful in treating stress related disorderes such as post traumatic stress disorder as well as depression, headache and anxiety |
| 09/05/2000 | US6114529 Useful for preparing camptothecin derivatives having antitumor activities |
| 09/05/2000 | US6114520 5'-deoxy-cytidine derivatives |
| 09/05/2000 | US6114517 Methods of modulating tumor necrosis factor α-induced expression of cell adhesion molecules |
| 09/05/2000 | US6114515 PIGRL-1, a member of immunoglobulin gene superfamily |
| 09/05/2000 | US6114424 Opalescent cosmetic compositions and methods for their preparation |
| 09/05/2000 | US6114397 Administering an antitumor agent to human patient |
| 09/05/2000 | US6114395 Method of treating atherosclerosis |
| 09/05/2000 | US6114394 Protecting mammalian cells from harmful cellular effects caused by exposure to ionizing radiation |
| 09/05/2000 | US6114393 Use of inhibitors of the sodium-hydrogen exchanger for the production of a pharmaceutical for the treatment of disorders which are caused by protozoa |
| 09/05/2000 | US6114392 A norbornane derivatives for reducing the side effect of agmatine, in the treatment of stroke and dementia |
| 09/05/2000 | US6114391 α-amino acid amides, preparation thereof and the therapeutical use thereof |
| 09/05/2000 | US6114389 Use of a pharmaceutically acceptable oxalate derivative for the treatment of skin conditions |
| 09/05/2000 | US6114388 Monofunctional and/or polyfunctional polylysine conjuages |
| 09/05/2000 | US6114387 Comprising ethylenediaminetetraacetic acid (edta) or salt thereof, n-acetyl-l-cysteine (nac) and a pharmaceutical formulating agent in tablet or capsule form |
| 09/05/2000 | US6114385 Administering l-carnitine, acyl l-carnitine derivatives or pharmacologically acceptable salts thereof for prophylaxis of diseases or treatment of cellular disorders caused by high levels of ceramide |
| 09/05/2000 | US6114383 Drugs inhibiting progress of pterygium and postoperative recurrence of the same |
| 09/05/2000 | US6114382 Diagnosing inflammatory bowel disease(ibd) by detecting presence of microsporidia; and administering a drug such as teclozan to kill living microsporidia in the patient's gastrointestinal tract; making an animal model of ibd |
| 09/05/2000 | US6114381 To control brain damage associated with anoxia or ischemia which typically follows stroke, cardiac arrest or perinatal asphyxia; compound is an antagonist to inhibit excitotoxic actions at excitatory amino acid receptor sites |
| 09/05/2000 | US6114377 For topical application, comprising an antimicrobial effective amount of 3-furancarboxylic acid combined with 2-furancarboxylic acid and optionally ferulic acid as an antiirritant; free of preservatives |
| 09/05/2000 | US6114376 Reversing agent is ll-f28249alpha-lambda series of compounds, the 23-oxo or 23-imino derivative thereof, the avermectins, the 22,23-dihydro derivatives thereof and the milbemycins |
| 09/05/2000 | US6114373 N-acetyl-5,6-dimethoxytryptamine and its free radical scavenging activity |
| 09/05/2000 | US6114372 Matrix metalloproteinase (mmp); tumor necrosis factor(tnf); compounds such as n2-((2s)-acetylmercapto)acetyl-5-phthalimidopentanoyl)-n1-((4 -methoxybenzene)sulphonyl)-n1-(phenylmethyl)hydrazine |
| 09/05/2000 | US6114370 Amnesic sedation composition and method of administering same |
| 09/05/2000 | US6114369 N-methyl-n-(1-(4-fluorobenzyl)benzionidazol-2-yl)-n'-methyl-n-(3,5 -bis(trifluoromethyl)benzylaminocarbonyl)-1,3-propylenediamine hydrochloride, for example; substance p antagonists; antiallergic activity |
| 09/05/2000 | US6114367 Such as 3-(3-cyclopentyloxy-4-methoxy)phenyl-2-isoxazoline-5-hydroxamic acid; treating sepsis, septic shock, inflammatory bowel disease, tuberculosis, graft versus host disease or cachexia associated with aids or cancer in a mammal |
| 09/05/2000 | US6114365 Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 09/05/2000 | US6114361 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives |
| 09/05/2000 | US6114360 Pyrrole compounds |
| 09/05/2000 | US6114359 Endothelin receptor antagonists |
| 09/05/2000 | US6114357 Hemoregulatory compounds |
| 09/05/2000 | US6114356 Method for treating gastrointestinal disorders using (+) norcisapride |
| 09/05/2000 | US6114355 Methods and compositions for inhibition of angiogenesis |
| 09/05/2000 | US6114353 Compositions and method for treatment of lymphomas, leukemias, and leiomyomas |
| 09/05/2000 | US6114352 Quinolinone derivative and anti-allergic agent with said quinolinone derivative as the active ingredient |
| 09/05/2000 | US6114351 N-oxides as antibacterial agents |
| 09/05/2000 | US6114349 Substituted quinoline derivatives with antiviral action |
| 09/05/2000 | US6114348 Method of treating warts using tazarotene |
| 09/05/2000 | US6114347 Pharmaceutical formulation for the prophylaxis and pretreatment of a poisoning caused by organophosphorus cholinesterase inhibitors |
| 09/05/2000 | US6114346 Treating sleep disorders using desloratadine |
| 09/05/2000 | US6114345 Phenylsubstituted 4-azasteroid fluoroderivatives |
| 09/05/2000 | US6114344 Long-acting local anesthetics |
| 09/05/2000 | US6114343 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-flurocytosin-1-yl)-1,3-oxathiolane |
| 09/05/2000 | US6114341 Treatment of atherosclerosis |
| 09/05/2000 | US6114339 Derivatives of pyrido [2,3-D] and [3,2-D] pyrimidine method of using these derivatives |
| 09/05/2000 | US6114338 Heterocyclic compounds |
| 09/05/2000 | US6114337 Zwitteronic-fatty acid compounds having anti-inflammatory properties |
| 09/05/2000 | US6114335 Benzoylguanidine derivatives, process for their preparation their use in the preparation of medicines |
| 09/05/2000 | US6114334 Piperazine derivatives as therapeutic agents |
| 09/05/2000 | US6114333 2-Pyrimidineamine derivatives and processes for their preparation |
| 09/05/2000 | US6114332 Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumor agents |
| 09/05/2000 | US6114331 Immunosuppressant |
| 09/05/2000 | US6114330 Substituted 2,4-diaminopyrimidines |
| 09/05/2000 | US6114329 5-HT4 receptor antagonists useful in the treatment of gastroinstestinal, cardiovascular and CNS disorders |
| 09/05/2000 | US6114328 Isoxazoline and isoxazole fibrogen receptor antagonists |
| 09/05/2000 | US6114327 Anti-viral compounds |
| 09/05/2000 | US6114326 Sleep disorders |
| 09/05/2000 | US6114324 Mirtazpine in water solution or suspension |
| 09/05/2000 | US6114323 Diabetic kidney disease; administering aminoguanidine |
| 09/05/2000 | US6114322 Anticholesterol agent |
| 09/05/2000 | US6114321 Porphyrin derivatives, pharmaceutical agents that contain the latter, and their use in photodynamic therapy and MRI diagnosis |
| 09/05/2000 | US6114320 Therapeutic treatment for VEGF related ocular diseases |
| 09/05/2000 | US6114318 17β-(2-oxo-tetrahydrofuranyl)-thio- substituted androstane derivatives |
| 09/05/2000 | US6114317 Method of locking 1α-OH of vitamin D compounds in axial orientation |
| 09/05/2000 | US6114316 Combination of bisphosphonate and tetracycline |
| 09/05/2000 | US6114315 Oral administering; side effect reduction |
| 09/05/2000 | US6114314 Formulations containing hyaluronic acid |
| 09/05/2000 | US6114313 Mixture of nucleotide, mannitol and adjuvants |
| 09/05/2000 | US6114312 Method of inhibiting human immunodeficiency virus by combined use of hydroxyurea, a nucleoside analog, and a protease inhibitor |
| 09/05/2000 | US6114311 Administering an adenviral compound |
| 09/05/2000 | US6114309 Combinatorial library of moenomycin analogs and methods of producing same |
| 09/05/2000 | US6114175 Amyloid-binding compounds which are non-azo derivatives of chrysamine g to determine degree of brain deposits quantitatively characterized by amyloidosis; down's syndrome; prevent cell degeneration; radioactive imaging |
| 09/05/2000 | US6114161 Isolated streptococcus sp pt strain dsm 8747 which produces a lipoteichoic acid used as an anticarcinogenic agent |
| 09/05/2000 | US6114109 Viral (HIV) growth inhibition |
| 09/05/2000 | US6113948 Microparticles and their use in wound therapy |
| 09/05/2000 | US6113944 Mixing with excipients and compression into tablets |
| 09/05/2000 | US6113942 Pharmaceutical composition for piperidinoalkanol compounds |
| 09/05/2000 | US6113941 Substained release microcapsule of physiologically active compound which is slightly water soluble at pH 6 to 8 |
| 09/05/2000 | US6113940 Drug delivery with transdermal patch layer which carries the cannabis chemical(s). the chemicals are contained in a film on the |
| 09/05/2000 | US6113937 Sustained release sufentanil compositions |
| 09/05/2000 | US6113934 Platinum complexes with anti-viral activity and method of using same |
| 09/05/2000 | US6113918 Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
| 09/05/2000 | US6113909 Pharmaceutical composition containing a mixed extract of Phellodendron amurense RUPRECHT cortex and Patrinia scabiosaefolia FISCH. for treatment of hepatitis C |
| 09/05/2000 | US6113906 Water-soluble non-antigenic polymer linkable to biologically active material |
| 09/05/2000 | US6113894 Treatment of blepharitis of the cornea of eyes, applying compositiion with viscosity adjusting agent, preservatives, buffers, nonionic surfactants and lipids |
| 09/05/2000 | US6113883 Hair styling compositions comprising silicone-containing copolymers |
| 09/05/2000 | US6113879 Isolated d-threo-methylphenidate enantiomorph; attention deficit-hyperactivity disorder; nontoxic |
| 09/05/2000 | US6113876 Methods of increasing sphincter competence |
| 09/05/2000 | US6113527 3,3-bis-hydroxymethyl-7-(cis-4-isopropyl-cyclohexyl)-1-phenyl -1,7-diaza-spiro-(3.5)nonane-2-one, for example; agonists of the orphanin fq (ofq) receptor; useful in the treatment of psychiatric, neurological and physiological disorders |
| 09/05/2000 | CA2279608C Container for moisture-sensitive material |
| 09/05/2000 | CA2188662C New method of treatment |
| 09/05/2000 | CA2116442C Novel glycosphingolipids and the use thereof |
| 09/05/2000 | CA2058428C Analgesic formulations |